Drawing for SOHNO

USPTO serial 90330649

SOHNO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GALBO, AMANDA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SOHNO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Heather Balmat

Heather Balmat BALMAT LAW, PLLC977 SEMINOLE TRAIL, #342CHARLOTTESVILLE, VA 22901UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware and peripheral devices; downloadable computer software and computer programs for use to collect and analyse medical samples; downloadable computer software using artificial intelligence for use in machine learning; downloadable computer software using artificial intelligence for use in autonomous decision making; downloadable computer software using artificial intelligence for machine learning of the identification of pathogens and disease biomarkers in the fields of clinical research, health care and health sciences; downloadable computer application software for computing devices, namely, software to control collection of medical samples and to perform analysis of medical samples; downloadable computer software for use to collect and analyse medical samples for use in connection with and as part of medical apparatus and instruments; downloadable clinical software, namely, database systems for patient medical information for use to store and analyse data; downloadable medical diagnostic software; downloadable computer operating system software; calculating machines and data processing equipment; electronic devices for storing, recording, transmitting and reproducing information, data or images, namely, computer hardware and peripheral devices for use in the fields of spectroscopy, collection and analysis of gases, and volatile organic compounds; diagnostic apparatus, not for medical purposes, for use to analyse chemical samples, namely, diagnostic apparatus for the detection of pathogens and disease biomarkers for laboratory or research use; chemical detection systems and apparatus, namely, analysers and testing sampling equipment for use to collect and analyse liquid, solid and gas samples in the nature of sorbent tubes for laboratory use in diagnostic testing, not for medical purposes; gas detectors for detecting the presence of gas, and particle detectors, namely, air quality measurement apparatus in the nature of particle counters; scientific apparatus, namely, spectrometers; temperature sensors, gas sensors for measuring gas concentration, pressure sensors; downloadable computer software for use in medical screening and diagnostics; pharmaceutical and scientific research equipment for use in mass spectrometers; laboratory equipment used for the scientific testing of gases, vapors, and particulate, namely, glass and metal sorbent tubes, in the nature of scientific research specimen collection devices for the purpose of capturing a breath sampleACTIVE—
010Medical devices, namely, breath gas analyzers for medical diagnostics in the nature of non-invasive devices for breath analysis, point-of-care diagnostic devices for breath analysis, infrared laser gas analysis devices for use to measure volatile compounds in breath or gas in the field of diagnostics and detection using non-invasive breath analysis and infrared laser gas analysis for use to measure volatile compounds in breath or gas in the field of diagnostics and detection using non-invasive breath analysis and infrared laser gas analysis; diagnostic apparatus for the detection of disease biomarkers, namely, breath gas analyzers for medical diagnostics; medical apparatus, namely, breath gas analysers for medical diagnostics; chemical detection systems and apparatus for medical diagnostic purposes consisting of analysers and sampling equipment for use to collect and analyse liquid, solid and gas samples; medical devices used for the collection, recording, concentration and analysis of volatile organic compounds in human breath, namely, breath gas analyzers for medical diagnostics; medical testing kits for detection of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver, namely, diagnostic kits consisting primarily of thermal desorption tubes for samples for use in medical diagnostic testing; testing apparatus for medical diagnostic purposes, namely, breath detectors being breath gas analyzers for use to detect disease biomarkers; detectors for medical purposes, namely, medical devices and diagnostic apparatus for the detection of pathogens and disease biomarkers; sensors for medical purposes, namely, respiratory sensorsACTIVE—
042Research services, namely, medical and scientific research services in the field of diagnostics and detection using non-invasive breath analysis and infrared laser gas analysis; scientific and technological services, namely, research and design in the field of computer data storage and interpretation of data; scientific and technological services, namely, scientific and technical consulting being information technology consultancy, scientific research, development and design of technology in the field of artificial intelligence and machine learning, and data analysis research being the compilation of data for research purposes in the field of artificial intelligence; design and development of machine learning computer software; design and development of computer hardware and software for medical and clinical use; medical research services; clinical research in the field of disease biomarkers; chemical analysis undertaken using a spectrometer to analyse disease biomarkers within gas, liquid and solid samples; chemical research; laboratory analysis in the field of chemistry; biological analysis using a spectrometer to analyse disease biomarkers within gas, liquid and solid samples; scientific laboratory services; scientific and medical laboratory testing services of disease biomarkers within gas, liquid and solid samples; medical research laboratory services; computer programming; product design and development of medical technology and medical apparatus; product research and development services relating to medical apparatus and instrumentsACTIVE—
044Medical services; consulting services relating to health care providers in the field of treating life-changing or life-threatening diseases; healthcare services, namely, providing medical information, health related consultancy, and advisory services related to health using artificial intelligence, machine learning, and data analysis in the fields of biomarker information services, and disease diagnosis; health advice and information services; medical health assessment services; health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; diagnostic health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 11, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 11, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 8, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 6, 2023EX1GSOU EXTENSION 1 GRANTED—
Feb 6, 2023EXT1SOU EXTENSION 1 FILED—
Feb 6, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 9, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 14, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 14, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 25, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 6, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 6, 2022XAECEXAMINER'S AMENDMENT ENTERED—
May 6, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 6, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
May 6, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 21, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 21, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 21, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 8, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 8, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 8, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 14, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 13, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 13, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 6, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2021DOCKASSIGNED TO EXAMINER—
Jan 25, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 23, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance